Hematopoietic stem cell mobilization

Haematologica

Volumn 93, Issue 3, 2008, Pages 321-324

  Lemoli, Roberto M ^a   D'Addio, Alessandra ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR CXCR4; CTCE 0021; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; HOX PROTEIN; PLERIXAFOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STROMAL CELL DERIVED FACTOR 1; T 140; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CELL THERAPY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; LYMPHOMA; MONOTHERAPY; MULTIPLE MYELOMA; NONHUMAN; PROTEIN INTERACTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SINGLE DRUG DOSE; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CELL ADHESION MOLECULES; CHEMOKINE CXCL12; CHEMOKINE CXCL2; CHEMOKINES; CHEMOKINES, CXC; DRUG SYNERGISM; FILGRASTIM; GENE EXPRESSION REGULATION; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELL MOBILIZATION; HETEROCYCLIC COMPOUNDS; HUMANS; MICE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECEPTORS, CHEMOKINE;

EID: 40849092541     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12616     Document Type: Review

References (38)

1. Abkowitz JL, Robinson AE, Kale S, Long MW, Chen J. Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood 2003;102: 1249-53.
2. Kollet O, Shivtiel S, Chen YQ, Suriawinata J, Thung SN, Dabev MD, et al. SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003;112:160-9.
3. Massa M, Rosti V, Ferrario M, Campanelli R, Ramaioli I, Rosso R, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005;105:199-206.
4. Lemoli RM, Catani L, Talarico S, Loggi E, Gramenzi A, Baccarani U, et al. Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. Stem Cells 2006;24:2817-25.
5. Schmitz N, Dreger P, Linch DC, Goldstone AH, Boogaerts MA, Demuynck HMS, et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet 1996;347:353-7.
6. Beyer J, Schwella N, Zingsem J, Strohscheer I, Schwaner I, Oettle H, et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 1995;13:1328-35.
7. Moncada V, Bolan C, Yau YY, Leitman SF. Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim. Transfusion 2003;43:495-501.
8. Anderlini P, Przepiorka D, Seong C, Smith TL, Huh Y, Lauppe J, et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion 1997;37:507-12.
9. Cottler-Fox MH, Lapidot T, Petit I, Kollet O, DiPersio JF, Link D, et al. Stem Cell Mobilization. In Hematology: Broudy VC, Prchal JT, Tricot GJ (editors) 2003. p. 419-37.
10. Adams GB, Scadden DT. The hematopoietic stem cell in its place. Nat Immunol 2006;7:333-7.
11. Yin T, Li L. The stem cell niches in the bone. J Clin Invest 2006;116:1195-201.
12. Kollet O, Dar Aylet, Lapidot T. The multiple roles of osteoclasts in host defense: bone marrow remodeling and hematopoietic stem cell mobilization. Annu Rev Immunol 2007; 25: 51-69.
13. Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA, et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006;124:407-21.
14. Bautz F, Denzlinge C, Kanz L, Moehle R. Chemotaxis and transendothelial migration of CD34+ hematopoietic progenitor cells induced by inflammatory mediator leukotriene D4 are mediated by the 7-transmenbrane receptor CysLT1. Blood 2001;97:3433-40.
15. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005;106:1901-10.
16. Ponomaryov T, Peled A, Petit I, Taichman RS, Habler L, Sandbank J, et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 2000;106:1331-9.
17. Rossi L, Manfredini R, Bertolini F, Ferrari D, Fogli M, Zini R, et al. The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. Blood 2007;109:533-42.
18. Kucia M, Ratajczak J, Ratajczak MZ. Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells. Biol Cell 2005;97:133-46.
19. Liles WC, Broxmeyer HE, Rodger E, Wood B, Hubel K, Cooper S, et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003; 102: 2728-30.
20. Devine SM, Flomemberg N, Vesole DH, Lieseveld J, Weisdorf D, Badel K, et al. Rapid mobilization of CD34+ cells following administration of the CXCR-4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin lymphoma. J Clin Oncol 2004; 22: 1095-102.
21. Liles WC, Rodger E, Broxmeyer HE, Dehner C, Badel K, Calandra G, et al. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte colony-stimulating factor by single administration of AMD3100, a CXCR-4 antagonist. Tansfusion 2005;45:295-300.
22. Flomemberg N Devine SM, DiPersio JF, Liesveld JL, McCarty JM, Rowley SD, et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 2005;106:1867-74.
23. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc C, Cooper S, Plett PA, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR-4 antagonist. J Exp Med 2005;201:1307-18.
24. Devine SM, Andritos L, Todt L, Vij, R Bonde J, Hess D, et al. A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donors hematopoietic stem cells in patients with advanced hematological malignancies. Blood 2005;106:299-304.
25. Pelus LM, Bian H, Fukuda S, Wang D, Merzouk A, Salari H. The CXCR4 agonist peptide CTCE-0021 rapidly mobilies polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor. Exp Hematol 2005; 33:295-307.
26. Abraham M, Biyder K, Begin M, Wald H, Weiss ID, Galun E, et al. Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003. Stem Cells 2007;25:2158-66.
27. Fukuda S, Bian H, King AG, Pelus LM. The chemokine GROb mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood 2007; 110:860-9.
28. Calvi LM, Adams GB, Weibrecht, KW, Weber JM, Olson DP, Knight MC, et al. Osteoblastic cells regulate the hematopoietic stem cell niche. Nature 2003;425:841-6.
29. Ballen KK, Shpall EJ, Avigan D, Yeap BY, Fisher DC, McDermott K, et al. Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Biol Blood Marrow Transplant 2007;13:838-43.
30. + cells in poor mobilizers. Blood 2004;103:3287-95.
31. Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani, L, et al. Proliferative response of human marrow myeloid progenitor cells to in-vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Exp Hematol 1995;23:1520-6.
32. Lemoli RM, de Vivo A, Damiani D, Isidori A, Tani M, Bonini A, et al. Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective to support myeloablative chemotherapy in patients with hematological malignancies and poor peripheral blood stem cell mobilization. Blood 2003;102:1595-600.
33. Isidori A, Tani M, Bonifazi F, Zinzani P, Curti A, Motta MR, et al. Phase II study of a single pegfilgrastim injection as adjunct to chemotherapy to mobilize stem cells into peripheral blood of pretreated lymphoma patients. Haematologica 2005;90:225-31.
34. Steidl U, Fenk R, Bruns I, Neumann F, Kondakci M, Hoyer B, et al. Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Bone Marrow Transplant 2005;35:33-6.
35. + peripheral blood progenitor cells in healthy family and unrelated donors. Haematologica 2005;90:1665-71.
36. Russell N, Mesters R, Schubert J, Boogaerts M, Johnsen HE, del Canizo C, et al. A phase 2 pilot study of Pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy. Haematologica 2008;93:405-12.
37. Morris ES, MacDonald KP, Rowe V, Johnson DH, Banovic T, Clouston AD, et al. Donor treatment with pegylated GCSF augments the generation of IL-10-producing regulatory cells and promotes transplantation tolerance. Blood 2004;103:3573-81.
38. Bruns I, Steidl U, Fischer JC, Czibere A, Kobbe G, Raschke S, et al. Pegylated G-CSF mobilizes CD34+ cells with different stem and progenitor cell subsets and distinct functional properties in comparison with unconjugated G-CSF. Haematologica 2008; 93:347-55.